Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclear cytometric changes in breast carcinogenesis.

E C Mommers1, N Poulin, J Sangulin

  • 1Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.

The Journal of Pathology
|February 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form.

Journal of clinical pathology·2001
Same author

Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes.

Journal of clinical microbiology·2001
Same author

High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.

The Journal of pathology·2001
Same author

Re: Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer.

Journal of the National Cancer Institute·2001
Same author

Lymphomatoid papulosis with a natural killer-cell phenotype.

The British journal of dermatology·2001

This study quantifies nuclear changes in breast tissue, revealing distinct progression pathways for well-differentiated and poorly differentiated breast cancers from precursor lesions. Florid ductal hyperplasia may represent an advanced stage with cancer precursor cells.

Area of Science:

  • Oncology
  • Pathology
  • Biomedical Imaging

Background:

  • Breast cancer development is hypothesized to involve a series of precursor lesions with increasing morphological alterations.
  • Understanding these early changes is crucial for identifying cancer development pathways.

Purpose of the Study:

  • To quantitatively analyze nuclear features using image cytometry across the spectrum of breast proliferative lesions, from normal tissue to invasive carcinoma.
  • To objectively describe nuclear changes and elucidate progression routes in intraductal and invasive breast lesions.

Main Methods:

  • Image cytometry was applied to tissue sections from normal breast tissue, usual ductal hyperplasia (UDH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) (well- and poorly differentiated), and invasive breast carcinomas (well- and poorly differentiated).

Related Experiment Videos

Main Results:

  • Progressive nuclear feature changes were observed from normal tissue to invasive carcinoma.
  • Florid ductal hyperplasia showed significant nuclear differences compared to mild/moderate UDH, suggesting it may be a more advanced precursor.
  • No significant nuclear differences were found between ADH and well-differentiated DCIS, indicating a close relationship.
  • Nuclear features of well-differentiated DCIS mirrored those of well-differentiated invasive carcinoma, and similarly for poorly differentiated lesions.

Conclusions:

  • Image cytometry effectively demonstrates progressive nuclear changes in breast lesions, supporting a pathway from UDH to ADH to invasive cancer.
  • Distinct progression routes exist for well-differentiated (via well-differentiated DCIS) and poorly differentiated (via poorly differentiated DCIS) invasive breast cancers.